期刊文献+

CD117、PDGFRA蛋白单独及联合DOG1检测在胃肠道间质瘤中的诊断价值 被引量:26

Diagnosis value of CD117, PDGFRA alone or in combination DOG1, as biomarkers for gastrointestinal stromal tumors
下载PDF
导出
摘要 目的:探讨组织中CD117、PDGFRA两种蛋白表达在胃肠道间质瘤(gastrointestinal stromal tumors,GIST)中的诊断价值及联合DOG1蛋白检测的意义。方法:回顾性对99例GIST和25例非GIST肿瘤标本进行CD117、PDGFRA和DOG1蛋白表达进行检测并进行相关性分析。结果:GIST组CD117、PDGFRA和DOG1蛋白表达率分别为93.94%(93/99)、53.54%(53/99)和90.91%(90/99),非GIST组分别为4.00%(1/25)、4.00%(1/25)和12.00%(3/25),组间比较均有统计学意义(P<0.05);GIST组性别、年龄、肿瘤直径、肿瘤部位、组织学类型和危险度分级等临床病理参数与CD117、PDGFRA和DOG1蛋白表达无统计学意义(P>0.05);CD117、PDGFRA、DOG1、CD117和DOG1联合、PDGFRA和DOG1联合及三者联合判断GIST的敏感性分别为0.989、0.981、0.968、0.960、0.933和0.961,特异性分别为0.800、0.343、0.710、0.840、0.947和0.955,ROC曲线下面积(AUC)分别为0.945、0.748、0.895、0.895、0.840和0.975。结论:GIST中CD117、PDGFRA及DOG1蛋白表达在胃肠道间质瘤中的优势人群有待进一步研究;CD117、PDGFRA蛋白单独及联合DOG1检测可提高对GIST诊断的准确度。 Objective: To explore diagnosis value of CD117, PDGFRA protein expression in combination DOG1 protein, as biomarkers for gastrointestinal stromal tumors. Methods: The protein CD117, PDGFRA and DOG1 levels were retrospectively tested and correlation analyzed in 99 cases of GIST specimens, 25 cases of non-GIST specimens.Results: The protein expression rates of CD117, PDGFRA and DOG1 were 93.94%(93/99), 53.54%(53/99)and 90.91%(90/99) in GIST group, and the protein expression rates of CD117, PDGFRA and DOG1 were 4.00%(1/25), 4.00%(1/25) and 12.00%(3/25) in non-GIST group, comparison between groups was statistically significant(P〈0.05); the expression of CD117, PDGFRA and DOG1 had no significant association with clinical pathological parameters of gender, age, tumor diameter, tumor location, histotype, or risk degree(P〈0.05);the sensitivity of CD117, PDGFRA, DOG1, CD117 combination DOG1, PDGFRA combination DOG1 and combination of the three was 0.989, 0.981, 0.968, 0.960, 0.933 and 0.961 in GIST, respectively; the specificity of CD117, PDGFRA, DOG1, CD117 combination DOG1, PDGFRA combination DOG1 and combination of the three was 0.800, 0.343, 0.710, 0.840, 0.947 and 0.955 in GIST, respectively; the area of ROC curve(AUC) of CD117, PDGFRA, DOG1, CD117 combination DOG1, PDGFRA combination DOG1 and combination of the three was 0.945, 0.748, 0.895, 0.895, 0.840 and 0.975 in GIST, respectively. Conclusion: The advantages people of CD117, PDGFRA and DOG1 protein expression need further research in GIST; CD117, PDGFRA alone or in combination DOG1 may improve the accuracy of diagnosis for GIST.
出处 《临床与病理杂志》 CAS 2015年第2期252-257,共6页 Journal of Clinical and Pathological Research
关键词 胃肠道间质瘤 CD117 PDGFRA DOG1 诊断 gastrointestinal stromal tumors CD117 PDGFRA DOG1 diagnosis
  • 相关文献

参考文献17

  • 1Reichardt P, Morosi C, Wardelmann E, et al. Gastrointestinal stromal tumors: evolving role of the multidisciplinary team approach in management [J]. Expert Key Anticancer Iher, 2012, 12(8 ): 1053-1068.
  • 2Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour[J]. Lancet, 2007, 369(9574): 1731-1741.
  • 3Kubin BP, Singer S, Tsao C, et al. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors[J]. Cancer Res, 2001, 61(22): 8118-8121.
  • 4Blay JY Le Cesne A, Cassier PA, et al. Gastrointestinal stromal tumors (GIST): a rare enti, a tumor model for personalized therapy, and yet ten different molecular subtypes[J]. Discov Med, 2012, 13(72): 357-367.
  • 5Miettinen M, Lasota J, Sobin LH. Gastrointestinal stromal tumors of the stomach in children and young adults: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases withlong-term follow-up and review of the literature [J]. Am J Surg Pathol, 2005, 29(10): 1373-1381.
  • 6Hoda KMj Rodriguez SA, Faigel DO. EUS-guided sampling of suspected GI stromal tumors[J]. Gastrointest Endosc, 2009, 69(7): 1218-1223.
  • 7Miettinen M, Wang ZF, Lasota J. DOG 1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases[J]. AmJ Surg Pathol, 2009, 33(9): 1401-1408.
  • 8Hwang DG, Qjan X, HornickJL. DOGI antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks[J]. AmJ Clin Pathol, 2011, 135(3): 448-453.
  • 9Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach[J]. Hum Pathol, 2002, 33(5): 459-465.
  • 10Faigel DO, Abulhawa S. Gastrointestinal stromal tumors: the role of the gastroenterologist in diagnosis and risk stratification[J]. J Clin Gastroenterol, 2012, 46(8 ): 629-636.

二级参考文献34

  • 1郑松,陈丽荣,王海军,罗月球,朱永良,程水珍,周燕.PDGFR-α在胃肠道间质瘤中的表达及其临床意义[J].浙江大学学报(医学版),2007,36(3):280-284. 被引量:6
  • 2Rossi CR, Mocellin S, Mencarelli R, Foletto M, Pilati P, Nitti D, Lise M. Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer 2003; 107: 171-176.
  • 3Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol 2005; 29: 52-68.
  • 4Dow N, Giblen G, Sobin LH, Miettinen M. Gastrointestinal stromal tumors: differential diagnosis. Semin Diagn Pathol 2006; 23: 111-119.
  • 5Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, Safioleas M. Gastrointestinal stromal tumor. World J Surg Oncol 2009; 7: 61.
  • 6Bórquez Ma P, Neveu C R. [Gastrointestinal stromal tumors. An update]. Rev Med Chil 2008; 136: 921-929.
  • 7Kang YN, Jung HR, Hwang I. Clinicopathological and immunohistochemical features of gastointestinal stromal tumors. Cancer Res Treat 2010; 42: 135-143.
  • 8Miettinen M, Wang ZF, Lasota J. DOG1 antibody in the differential diagnosis of gastrointestinal stromal tumors: a study of 1840 cases. Am J Surg Pathol 2009; 33: 1401-1408.
  • 9Joensuu H. Risk stratification of patients diagnosed with gastrointestinal stromal tumor. Hum Pathol 2008; 39: 1411-1419.
  • 10Corless CL, Heinrich MC. Molecular pathobiology of gastrointestinal stromal sarcomas. Annu Rev Pathol 2008; 3: 557-586.

共引文献32

同被引文献173

引证文献26

二级引证文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部